| 标题 |
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Siow Ming Lee; Christian Schulz; Kumar Prabhash; Dariusz M. Kowalski; Aleksandra Szczęsna; et al 出版日期:2023-07-06 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)